Low-grade endotoxemia in SIBO will activate the TLR-4 and CD14 receptors, which will activate the NF-κB pathway and lead to the expression of inflammatory cytokines [8, 36]. The gene discussed is NFKB1; the disease is serum lipopolysaccharide activity.